GHRP-2 – 5MG/10MG

Scientific Overview of GHRP-2

GHRP-2, also referred to as Pralmorelin, is a synthetic pentapeptide studied for its potential interactions with ghrelin receptors. It shares structural resemblance to met-enkephalin but does not appear to exhibit the typical properties of neurotransmitters.

Alternative Names: Pralmorelin

GHRP-2 Studies and Research Data

Investigations into Pituitary Interactions

Research suggests that GHRP-2 may engage with growth hormone secretagogue receptors, initiating intracellular signaling cascades involving secondary messengers. These processes are considered relevant to the modulation of growth hormone secretion in experimental contexts.

GHRP-2 Explorations in Hormone Regulation

Experimental studies propose that GHRP-2 could increase growth hormone output beyond levels seen with other regulatory peptides. Observations have also noted possible associations with insulin-like growth factor-1 (IGF-1) activity under laboratory conditions.

Observations in Muscle Biology

Animal model studies, including research in yaks, suggest that te peptide may support protein synthesis and potentially reduce protein breakdown, thereby influencing muscle deposition in challenging growth environments.

GHRP-2 Insights from Cardiovascular Models

Some experiments theorize that GHRP-2 and related analogs may contribute to reduced oxidative stress in vascular systems and support cardiac cells under stress-related conditions. Receptor pathways such as CD36 have been implicated in these exploratory findings.

Connections with Immune Pathways

Preclinical findings imply that GHRP-2 might influence thymus-associated processes, potentially supporting T-cell populations and suggesting a role in immune system regulation.

Experimental Perspectives on Pain and Neurological Models

Research has proposed that GHRP-2 may interact selectively with opioid receptors associated with pain pathways. This distinct mode of action is considered different from the broad activity observed in other compounds affecting opioid systems.

GHRP-2 Studies on Sleep and Appetite

Early findings suggest that GHRP-2 may alter sleep cycles, particularly deep sleep and REM phases. Separate research models indicate a role in appetite regulation through ghrelin receptor activation, with increases in food intake observed compared to controls.

Conclusion

Scientific exploration of GHRP-2 spans multiple areas, including pituitary signaling, hormonal modulation, muscle biology, cardiovascular stress models, immune pathways, pain perception, and sleep and appetite regulation. While results remain preliminary, they suggest broad areas of interest for continued investigation.

References

1. Titterington JS, Sukhanov S, Higashi Y, Vaughn C, Bowers C, Delafontaine P. (2009). Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis. Endocrinology.
2. Phung LT, Inoue H, Nou V, Lee HG, Vega RA, Matsunaga N, Hidaka S, Kuwayama H, Hidari H. (2000). The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine. Domest Anim Endocrinol.
3. Zeng P, Li S, Zheng YH, Liu FY, Wang JL, Zhang DL, Wei J. (2014). Ghrelin receptor agonist, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice. Peptides.
4. Bowers, C. Y., Granda, R., Mohan, S., Kuipers, J., Baylink, D., & Veldhuis, J. D. (2004). Sustained elevation of pulsatile growth hormone (GH) secretion…. J Clin Endocrinol Metab.
5. Hu R, Wang Z, Peng Q, Zou H, Wang H, Yu X, Jing X, Wang Y, Cao B, Bao S, Zhang W, Zhao S, Ji H, Kong X, Niu Q. (2016). Effects of GHRP-2 and Cysteamine Administration on Growth Performance… in Yaks. PLoS One.
6. Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor…. Transl Androl Urol.
7. Chao YN, Sun D, Peng YC, Wu YL. (2016). Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation…. Int J Mol Sci.
8. Sigalos JT, Pastuszak AW. (2018). The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev.
9. Laferrère B. et al. (2005). Growth hormone releasing peptide-2, like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab.
10. Veldhuis JD, Keenan DM, Bailey JN, Adeniji AM, Miles JM, Bowers CY. (2009). Novel relationships of age… to growth hormone releasing peptide efficacies in men. J Clin Endocrinol Metab.

Disclaimer:
The products mentioned are intended solely for laboratory research and in-vitro experimentation. They are not approved for human or animal use of any kind. All details provided are for educational purposes only. By purchasing from this site, you agree to comply with our Terms and Conditions.